Bristol-myers Squibb: Oncology Franchise Remains a Core
Bristol-Myers Squibb Company ($BMY) hits a 52-week high as sales of its cancer treatment drug Breyanzi surge, with…
67d agoOil Prices Were Mixed in the Morning Asian Session • Gold Prices Slipped Below $5,000 in Thin Trading • Trump Says He Will Be Involved Indirectly in U.S.-Iran Nuclear Talks in Geneva • Global Investors Stay 'Uber-Bullish' as AI Bubble Fears Rise • Aluminum Surges on Trump Tariff Rollback Talk • Oil Prices Were Mixed in the Morning Asian Session • Gold Prices Slipped Below $5,000 in Thin Trading • Trump Says He Will Be Involved Indirectly in U.S.-Iran Nuclear Talks in Geneva • Global Investors Stay 'Uber-Bullish' as AI Bubble Fears Rise • Aluminum Surges on Trump Tariff Rollback Talk
Amgen Inc. ($AMGN) shares are poised for a potential surge, according to a bullish thesis outlined by OppCost on R. Dennis’s Substack, citing the company’s…
57d agoBristol-Myers Squibb Company ($BMY) hits a 52-week high as sales of its cancer treatment drug Breyanzi surge, with…
67d agoGoldman Sachs has raised its price target on $TEVA to $45 from $36, and given it a Buy…
67d agoGet the 10 most important stories delivered to your inbox every morning. No spam. Unsubscribe anytime.